Stanford, UCSF Assay That Tags JMML Cells Could Help Identify New Treatments | GenomeWeb
Researchers at Stanford University and the University of California at San Francisco have developed a phosphospecific flow cytometry technique to profile signaling at the single-cell level, including molecules downstream of the granulocyte-macrophage colony-stimulating factor receptor and molecules closely associated with Ras signaling.
The cell populations will be evaluated for the presence of primary juvenile myelomonocytic leukemia, or JMML, cells with altered signaling behavior correlated with disease physiology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.